Occupational Risk

Management Of Significant Occupational Exposures To Hepatitis C Virus

Published in Medical Letter on the CDC and FDA, August 11th, 1997

The latest U.S. Centers for Disease Control and Prevention guidelines regarding occupational exposure to hepatitis C virus (HCV) recommend against post-exposure prophylaxis with antiviral agents such as alpha interferon or with immunoglobulin.

They do recommend, however, that health care workers who sustain percutaneous or permucosal exposures to anti-HCV positive blood should be followed up actively. This includes immediate testing of the source patient for anti-HCV and, if positive, testing the exposed person at the time of injury for anti-HCV and after six months for anti-HCV and alanine amino transferase activity.

Guidance on the management of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (1997-08-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry